A bivalent compound targeting CCR5 and the mu opioid receptor treats inflammatory arthritis pain in mice without inducing pharmacologic tolerance
Bioportfolio,
Pain accompanies rheumatoid arthritis and other chronic inflammatory conditions and is difficult to manage.